Revida Recovery Centers

06/25/2025

Do you know how long acute withdrawals last? Read our blog post to learn more about the timeline.

How long does op**te withdrawal last? Our latest blog dives into everything you need to know.

06/23/2025

If you’re coping with acute withdrawals, we suggest you use these tools.

06/20/2025

Are you familiar with the causes of opioid withdrawal? Let’s review some of the basics.

06/18/2025

Suboxone treatment is a safe, effective way to minimize withdrawal symptoms. This empowers our patients to focus on the psychological part of recovery sooner. To refer a patient to our program, visit our website or call us at 423-631-0432.

Suboxone® treatment services with ReVIDA are suited to your recovery journey. Contact us for same day treatment

06/16/2025

Do you know how to safely administer Naloxone? Check out this free resource from the Tennessee state government and learn how to save a life during an opioid overdose.

06/13/2025

We believe you deserve to be with people who truly care when you receive treatment.

06/11/2025

If you aren’t sure you can afford treatment, please don’t give up hope. Our Treatment for All program offers scholarships to Tennesseans who can’t pay for treatment on their own. To find out if you qualify, visit our website or call us at 423-631-0432.

ReVIDA has funding available for qualifying Tennessee residents that can help pay for your treatment whether you are insured or uninsured. If you have health insurance, these funds can cover up to 100% of your copay, deductible, and coinsurance! If you are uninsured, these funds can cover 100% of th...

06/09/2025

In 2024, a Yale-led study found that extended-release injectable buprenorphine medication is effective at treating opioid use disorder. Specifically, the medication minimized the impact of withdrawals.

This study backs up what we at ReVIDA® have known for years: medication-assisted treatment saves lives by empowering people in recovery to safely and effectively heal from OUD.

Read the study to learn more about the results:

This nonrandomized trial evaluates whether a 7-day injectable preparation of extended-release buprenorphine is acceptable, well-tolerated, and safe for patients with minimal to mild opioid withdrawal.

06/06/2025

Learning to manage your symptoms in recovery is key. What tools do you use for managing PAWS?

06/04/2025

Would you be able to recognize the symptoms of post-acute withdrawals in yourself or a loved one?

06/02/2025

As many as 90% of people with opioid use disorder are estimated to experience post-acute withdrawal symptoms (PAWS) during recovery, according to a 2021 study. However, many people in recovery are unfamiliar with the phenomenon.

Our recent blog post on the topic explains what PAWS is and how it affects people in recovery:

Read our blog to understand more about how post-acute withdrawal syndrome (PAWS) might affect your recovery from opioid use disorder (OUD).

05/30/2025

As we wrap up , we must continue to prioritize mental health during treatment for opioid use disorder. What strategies do you use to prioritize mental health during recovery?